Cosmetic injectables are more听听补苍诲听听than ever. In 2024, the Australian market was estimated to be worth听听(A$4.6 billion) and growing fast.
But these aren't simple beauty treatments. They use serious prescription medicines such as botulinum toxin (Botox) 鈥 the听听ever discovered 鈥 and can cause severe complications including听,听.
New national guidelines for听听补苍诲听听came into effect听听to improve safety.
Yet a听听still governs how these "poisons" are prescribed, administered and supplied across the country. Is it time they were made consistent nationally?
A long push
Scholars have long听听听in听.
Some 25 years ago, a听听found variation in state poisons laws created "a major cost for industry and, in turn for consumers".
More recently, the Queensland Minister for Health has听听uniform injectables laws across Australia.
This fragmentation might also conflict with Australia's听, which states patients should have uniform access to medicines across all jurisdictions.
What do the laws actually say?
In New South Wales, prescriptions for cosmetic injectables are valid for just听. But in听,听听听听, they last 12 months.
This means patients can legally receive the treatment for twice as long based on a single consultation.
The laws also govern who can buy and keep injectables. Queensland uniquely allows nurses to purchase and hold stocks of Botox, but only under strict conditions requiring听. Nurses can鈥檛 buy Botox in other states.
Most other states, such as听听补苍诲听, follow a traditional doctor-prescribe,听听model under general prescription drug laws, without the special cosmetic injectable regulations found in Queensland or NSW.
Victoria听听to take "all reasonable steps to ensure a therapeutic need exists" before prescribing cosmetic injectables. In Queensland,听听"reasonably necessary for therapeutic treatment".
This may create ambiguity for some cosmetic uses that may not qualify as "therapeutic". These could be considered ""听uses (those not approved by the regulator), such as facial asymmetry correction.
But other jurisdictions have no such explicit "therapeutic need" provisions in their legislation.
Why do the laws differ?
Inconsistent state laws in health are听听in Australia.
When the Constitution was framed in 1901, the federal government听听a specific power to make听.
Instead,听听as an ""听from their colonial days.
Today, the federal Therapeutic Goods Administration (TGA) classifies substances like Botox as prescription-only through听. It鈥檚 a system dating back to an 1862 "".
But due to the states' authority, this federal classification only becomes law once the states adopt it. While all states have adopted the federal standard, they have also added their own rules.
Significant differences between jurisdictions can create听,听听and put both听听at risk.
Is uniformity the answer?
While uniform laws sound appealing, the real problems might lie elsewhere.
Media investigations have revealed an alleged 鈥溾 for prescription medicines.
There are reports of some telehealth consultations being听, lasting under a minute.
Crucially, both practices already violate existing professional standards. The regulator, the Australian Health Practitioner Regulation Agency (AHPRA), promotes听. It says it receives regular reports of "inappropriate consultations".
State laws also prohibit unauthorised supply. NSW's听听prohibits direct-to-consumer supply without authorisation.
听补苍诲听听laws contain similar prohibitions.
The issue isn鈥檛 missing rules. It's听.
One exception involves unregistered people administering injectables at parties, as occurred in听听this year, causing life-threatening botulism.
But even here, the solution isn鈥檛 necessarily harmonising state laws.
Poisons legislation already makes unauthorised administration illegal. This is the case for听,听, and听, and in听听.
And as some practitioners听, making legitimate channels harder to access may only drive more people underground.
Both state and federal laws regulate poisons, including botox. Image credit: Jonathan Borba/Pexels
50
automatic
LinkA better path forward
Rather than harmonising state laws 鈥 a constitutionally difficult task 鈥 Australia has chosen a different approach: strengthened professional standards.
The new听听directly tackle the telehealth "rubber-stamping" problem by requiring doctors to conduct real-time consultations with detailed informed consent for every patient.
Combined with the听, adopted in听, and听, this creates uniform conduct expectations across Australia, even with different state laws.
Even with perfectly harmonised laws, enforcement would still depend on different state regulators with varying resources and priorities.
By contrast, there is already a high level of consistency in the way AHPRA and the听听address complaints.
The听听already provides largely consistent standards nationwide, including on how听 to discipline practitioners.
Recommendations from an听听released just this week also call for more national coordination across the country.
So while the cosmetic injectable industry needs better regulation, uniform state poisons legislation may not be the priority in this instance.
Republished under Creative Commons license from听.
Header image: AdobeStock
Manual Name : Dr Christopher Rudge
Manual Description : Sydney Health Law
Manual Address :
Manual Addition Info Title :
Manual Addition Info Content :
Profile image : /content/dam/corporate/images/sydney-law-school/people/christopher-rudge.jpg
Manual Type : profile
_self
Auto Type : contact
Auto Addition Title :
Auto Addition Content :
Auto Name : true
Auto Position : true
Auto Profile image :
Auto Phone Number : false
Auto Mobile Number : true
Auto Email Address : true
Auto Address : false
UUID :
Manual Name :
Manual Description :
Manual Address :
Manual Addition Info Title :
Manual Addition Info Content :
Profile image :
Manual Type : contact
_self
Auto Type : contact
Auto Addition Title :
Auto Addition Content :
Auto Name : true
Auto Position : true
Auto Profile image :
Auto Phone Number : false
Auto Mobile Number : true
Auto Email Address : true
Auto Address : false
UUID : I-SHIH1